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CONGENITAL TRITANOPIA: A COMPARISON OF TWO CLINICAL CASES 
James Kundart OD MEd FAAO FCOVD-A, Emma Lundien, BS, OD Candidate, Ron Mearsha, OD, Janice Pierce, OD, Oliver Kuhn-Wilken, OD 
 
College of Optometry | Pacific University | Pacific EyeClinic Portland | 511 SW 10th Ave, Suite 500| Portland, Oregon 97205 
ABSTRACT	  
This poster explores two cases of presumed blue-
yellow color deficiency in order to help 
optometrists care for this rare class of patients. 
Since this condition is extremely uncommon at 
birth, and is not possible to see by looking in the 
eye, practitioners may miss the subtle signs and 
less subtle symptoms. Optical treatment options 
are also discussed. 
SUBJECTIVE	  FINDINGS	  
OBJECTIVE	  FINDINGS	  
For patient #1, refractive testing revealed low 
myopia and 6Δ esophoria at near. A full exam and 
color testing was performed using the Optec 2000 
and the patient scored a 3/5, and a 2/5 on repeat 
testing. Note that this color vision test is for red-
green defects. 
 
Patient #2 had a manifest Rx: OD -5.00 -0.50 x 
160 VA 20/15, OS -5.75 DS VA 20/20+1. 
Extraocular motilities were full, as was a 
screening visual field. Pupils were large, but 
equal, round and reactive to light, with no afferent 
pupillary defect. Intraocular Pressures were 15/15 
@ 9:50 AM with an iCare tonometer.  
 
Patient #2 was also tested with Short-Wavelength 
Automated Perimetry, also known as SWAP, or 
blue-yellow visual fields, which showed moderate 
depression in the mid-peripheral. Scanning retinal 
laser in the form of OCT (Optical Coherence 
Tomography) showed no thinning of any of the 
retinal layers. A retinal fundus photo and Cirrus 
OCT of the right eye is shown in Figure 2 and 
Figure 3. 
ASSESSMENT	  &	  PLAN	  
Patient #2 was diagnosed with mild to moderate 
congenital tritanomaly.  He was educated about 
the genetic nature of his condition, which was 
supported by his family history.	  He did not request 
any treatment beyond his habitual prescription, 
but based on the treatment for patient #1, blue #1 
tint was recommended, as detailed above. 
Patient #1 was diagnosed photophobia secondary 
to moderate to severe tritanomaly. This condition 
was presumed to be congenital, and was likely 
contributing to his headaches. Congenital color 
vision deficiencies are not expected to progress. 
 
For patient #1, because standard sunglasses did 
little to alleviate symptoms and caused too much 
disruption with indoor activities, varying levels of 
blue tint was trial framed, and blue #1 was the 
preferred tint by the patient. The patient came for 
a CVE two years later and was enjoying 
comfortable vision using the blue #1 tint on his 
lenses. At this appointment, the patient reported 
being diagnosed with transverse myelitis of the 
spine. This kind of inflammation can lead to 
demyelination, but is not expected to affect vision. 
CONCLUSIONS	  
LITERATURE	  CITED	  
CONTACT	  INFORMATION	  
For tritan patients, we suspect that the blue lenses 
acted as a neutral density (or gray) filter for the 
patient. This is because tritans see gray at 380 
nm, which is the violet end of the visible spectrum. 
 
For diagnosis, we recommend the following 
testing:	  
• 	  Hardy-Rand-Rittler (HRR) testing is 
recommended, which includes screening and 
diagnostic pseudoisochromatic plates for mild, 
moderate, and severe tritan defects. 
•  When available, SWAP (Short-Wavelength 
Automated Perimetry), or blue-yellow visual fields 
may yield additional information (see Figure 4, 
below). 
	  
1.  h%p://en.wikipedia.org/wiki/
Charles_Edward_Stuart	  
2.  	  h%p://commons.paciﬁcu.edu/coofac/28/	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Congenital tritan color vision defects are an 
autosomal dominant genetic condition affecting 
0.005% of Caucasian males. This translates to 
one in 20,000 patients. Two suspected blue-
yellow color deficient cases are discussed below. 
	  
Patient #1 was a 32-year-old white male with a 
chief complaint of increased sensitivity to lights in 
both eyes, and headaches. Wearing sunglasses 
over his contact lenses was shown to reduce 
symptoms, but on further questioning, the patient 
reported substantial photophobia even with 
sunglasses. Ocular and medical histories were 
unremarkable, except the patient reported 
smoking less than one pack of cigarettes per day.  
 
Patient #2 was a 27-year-old white male. His 
concern was difficulty seeing in bright light, and 
especially when facing the setting sun. The 
problem was in both eyes, stable more or less 
since birth, relieved slightly by anti-reflective 
coating and Transitions photochromic lenses. His 
difficulties were severe. Under the conditions 
described above he can only see six inches in 
front of his face, though with Transitions in his 
glasses his range is extended to three feet.  
 
Patient #2 reports that he is missing sensitivity to 
blue, which looks gray to him. He has a very 
difficult time reading e-books, though does better 
on Kindles. His computer is always on the 
dimmest illumination, his house is constantly 
blacked out with shades, and he uses 60W bulbs 
or less. He states that he has above-average 
night vision. He relies mainly on his hearing to 
cross intersections without getting hit. 
  
Patient #2 had a normal birth as far as he knows, 
without supplemental oxygen or forceps. He 
reports his nutrition to be good, and his systemic 
health unremarkable, not taking any medications. 
Figure 4: SWAP (Blue-Yellow) Visual Field for 
the right eye of Patient #2. OS was similar. 
Figure 2: Right retina of patient #2. OS was similar. 
Figure 3: Right Cirrus OCT of patient #2. OS was similar. 
 
Figure 1: Charles Edward Stuart, or “Bonnie Prince Charlie,” 
who may have passed on the tritan gene to patient #2 
Patient #2 reported that his father has the same set of 
symptoms, and likely his PGF as well. He has been 
seen by three eye care physicians already and has 
been told that he was “making things up.” 
 
Patient #2 reported that he was a direct descendant of 
the House of Stewart, and he states that his lack of 
blue sensitivity goes back generations and includes 
Bonnie Prince Charlie (Figure 1).	  
For treatment, we recommend a blue tint to improve 
visual comfort. Blue-blocker (yellow) tints would we 
predicted to make their vision less comfortable, as 
was proven to be the case with patient #1. 
